Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Chardan’s 7th Annual Genetic Medicines ConferenceFireside Chat: Monday, October 2, 2023 at 4:00 pm ET Location: The Westin New York Grand Central, New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

JonesTrading 2023 Healthcare SummitOctober 10-11, 2023Location: Eden Rock Miami Beach, Miami, FL

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076[email protected]

You May Also Be Interested In

• Form 8.3 - Picton Property Income Limited
• Nokia's Sustainability Strategy: An Engine for Innovation, Collaboration, and Long-Term Impact
• Bottle Nexus, The Leading Direct-To-Consumer Alcohol Compliance and Checkout Platform, Sees Tremendous Company Growth Across Organization; Growing at a YOY growth of over 25%, Securement of Over 500 A